Study to Evaluate Progression Free Survival in Cancer Patients With Advanced Colorectal Carcinoma With AMT2003
NCT00405561
·
clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
TERMINATED
Status
67
Enrollment
INDUSTRY
Sponsor class
Stopped
Lack of efficacy
Conditions
Colorectal Carcinoma
Interventions
DRUG:
AMT2003
Sponsor
Auron Healthcare GmbH